Finance

Lists
Q1 2027 earnings • released • EPS beat +50.01% • Revenue beat +7.03%
See results
NEOG:NASDAQ
Neogen Corp
$11.85
+1.20%
(+0.14) 1D
$12.02
+1.43% (+0.17)
After hours
Closed: Oct 9, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NEOG...
Open
$11.71
High
$12.11
Low
$11.57
Mkt. cap
2.59B
Avg. vol.
4.43M
Volume
3.65M
52-wk high
$14.18
52-wk low
$5.37
EPS
-$0.25
Beta
1.79
Shares outstanding
218.31M
No. of employees
3K
Open
$11.71
High
$12.11
Low
$11.57
Mkt. cap
2.59B
Avg. vol.
4.43M
Volume
3.65M
52-wk high
$14.18
52-wk low
$5.37
EPS
-$0.25
Beta
1.79
Shares outstanding
218.31M
No. of employees
3K
News stories
From web sources and news partners
Profile
Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abused and therapeutic drugs in animal treatment. In 2009, it became a vendor of the Chinese government and has been engaged in researching China-specific food safety and plant health issues. Wikipedia
About Neogen Corp
CEOJohn Adent
Employees2.64K
Founded1982
Headquarters-
SectorMedical device
Websiteneogen.com
Analyst ratings
Based on 3 analysts giving stock ratings to NEOG in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NEOG in the last 3 months.
Highest
Current $11.85
$14.00 (+18.14%)
Average
$14.00 (+18.14%)
Lowest
$14.00 (+18.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Westenberg
Piper Sandler
Buy
Maintained
$14.00
+18.1%
10/07/2026
Subbu Nambi
Guggenheim
Buy
Maintained
$14.00
+18.1%
09/29/2026
Brandon Vazquez
William Blair
Hold
Maintained
-
-
09/28/2026
Last report
Oct 6, 2026
Fiscal period
Q1 2027
$0.08 / $0.05
+50.01%beat
Revenue / Est. (USD)
222.80M / 208.18M
+7.03%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Nov 2025
Feb 2026
May 2026
Aug 2026
Revenue
224.69M
211.20M
225.30M
222.80M
Cost of goods sold
118.01M
112.20M
117.50M
117.30M
Cost of revenue
118.01M
112.20M
117.50M
117.30M
Research and development expenses
4.56M
3.80M
4.90M
6.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
107.50M
98.50M
99.80M
100.80M
Operating expense
112.06M
102.30M
104.70M
107.30M
Total operating expenses
230.07M
214.50M
222.20M
224.60M
Operating income
-5.38M
-3.30M
3.10M
-1.80M
Other non operating income
-477.00K
-3.10M
4.50M
1.10M
EBT including unusual items
-20.36M
-20.30M
-12.10M
-14.90M
EBT excluding unusual items
-20.36M
-20.30M
-12.10M
-14.50M
Income tax expense
-4.44M
-3.30M
-800.00K
-3.00M
Effective tax rate
21.80%
16.26%
6.61%
20.13%
Other operating expenses
-
-
-
-
Net income
-15.92M
-17.00M
-11.30M
-11.90M
Net profit margin
-7.09%
-8.05%
-5.02%
-5.34%
Earnings per share
0.10
0.09
0.09
0.08
Interest and investment income
592.00K
-
-
-
Interest expense
-14.85M
-13.90M
-13.90M
-13.80M
Net interest expenses
-14.26M
-13.90M
-13.90M
-13.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
23.55M
25.62M
32.50M
27.30M
Gain or loss from assets sale
267.00K
224.00K
-
500.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps